Therapy Areas: Vaccines
13 June 2019 - - German biotechnology company Sirion Biotech GmbH has entered into a license agreement with the National Institute of Allergy and Infectious Diseases (NIAID), part of th...
10 June 2019 - - US-based immunotherapy company NantKwest (NASDAQ: NK) has appointed Cheryl L. Cohen to the board of directors of NantKwest, effective immediately, the company said.
Since 2...
7 June 2019 - - US-based oncolytic immunotherapy company OncoMyx Therapeutics, which was founded on the myxoma virus platform from Arizona State University, has closed a USD 25m series A financing led...
7 June 2019 - - Japanese pharmaceutical company Takeda Pharmaceutical Company Ltd. (TSX: 4502) (NYSE: TAK) said the Phase 3 TOURMALINE-AL1 clinical trial in patients with relapsed or refractory system...
6 June 2019 - Eiger BioPharmaceuticals Inc (Nasdaq: EIGR), a company focused on the development and commercialisation of therapies for rare diseases, announced yesterday that it has named Jeysen Yogar...
5 June 2019 - - US-based clinical-stage biotechnology company Moderna, Inc., (NASDAQ: MRNA) has presented interim data from an ongoing Phase 1 clinical study in patients with both resected (adjuvant) ...